Abbott Plans to Separate Nutrition Business Into Independent Public Company
Abbott plans to separate its $8.5 billion global Nutrition business into an independent, publicly traded company through a tax-free share distribution to existing shareholders. The transaction is targeted for completion by the end of 2027, contingent upon regulatory approvals, registration statement effectiveness, and final board approval. This strategic move aims to establish the standalone entity as a pure-play leader in the growing healthy nutrition market while streamlining Abbott’s core portfolio operations.
Abbott (NYSE: ABT) announced its intention to separate its global Nutrition business into an independent, publicly traded company. The Nutrition business has approximately $8.5 billion in annual sales.
Abbott intends to carry out the separation by distributing shares of the independent Nutrition company to Abbott shareholders. The company described the planned standalone business as a global leader in the rapidly expanding healthy nutrition market.
Abbott expects to complete the transaction by the end of 2027. The planned separation remains subject to customary conditions, including regulatory approvals, the effectiveness of a registration statement on Form 10 and final approval by the Abbott Board of Directors.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.